Wound care specialist Advanced Medical Solutions Group PLC (LON:AMS) has received the green light from the US regulator for two new products.
The Food & Drug Administration granted premarket 510(k) approvals for the group's post-operative dressing and foam dressing.
"These most recent approvals strengthen our advanced wound care portfolio in the US and provide further significant products to support our OEM customers and end users,” said chief executive Chris Meredith.
“We are particularly pleased to be able to demonstrate the value of our R&D and regulatory capabilities which are a key pillar of our strategy to drive organic growth."